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Abstract
In systemic lupus erythematosus (SLE), the availability of self-antigen promotes and fuels self-reactive immune responses.
Apoptotic cells represent a major source of self-antigens, and an impairment of the removal of apoptotic material
containing self-antigen can contribute to the development of autoimmunity. To address whether the adipocytokine leptin -
which favors autoimmune responses through little understood mechanisms - could modulate the handling of apoptotic
cells in SLE, we evaluated the ability of leptin to modulate the capacity of macrophages to phagocytose apoptotic bodies in
(NZB6NZW)F1 lupus mice. It was found that leptin promoted phagocytosis of apoptotic cells by macrophages by
modulating cAMP levels in macrophages. This finding associated with an increased availability of antigen that favored the
development of T cell responses to apoptotic-derived antigen. As leptin promotes macrophage phagocytosis of apoptotic
bodies in SLE and subsequent availability of apoptotic-derived antigen to T cells, an inhibition of this process via leptin
blockade might have a therapeutic potential in SLE.
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Introduction
Apoptotic cell death and subsequent clearance of apoptotic
bodies have an important role in the maintenance of immune
tolerance. A dysregulation of apoptosis and/or an altered
clearance of apoptotic material can lead to the development of
autoimmunity. [1] For example, a defective clearance of apoptotic
cell-derived material has been described in systemic lupus
erythematosus (SLE) patients and in lupus-prone mice [2–3].
SLE is a systemic autoimmune disease in which autoreactive
immune responses attack multiple tissues, causing inflammation
and tissue damage that can lead to a significant loss of organ
function. The reasons why the course of SLE can alternate periods
of illness with remissions are not well understood, although there is
consensus that those aspects may be driven by factors that
modulate the inflammatory state of the patient. [4] As a
consequence of this gap of information, the treatment of SLE
mainly relies on the use of immunosuppressive drugs that inhibit
immune responses in a rather non-specific manner, to reduce
inflammation [5].
Leptin is an adipocytokine that regulates metabolism [6] and
modulates immune responses. [7] Leptin has structural similarities
with the cytokines of the long-chain helical family, and displays
proinflammatory properties that are most evident in inflammation
and in autoimmunity. [7–8] The levels of this adipocytokine are
increased in infection and in inflammation, or after exposure to
inflammatory stimuli such as LPS, TNF-a, and IL-1. [7]
Circulating leptin is also elevated in most SLE patients, and
appears to contribute to proinflammatory events associated with
the disease [9–10].
Since the generation and availability of self-antigen are
important elements in the development and maintenance of tissue
inflammation in SLE, we investigated how leptin influenced those
aspects in the pathogenesis of SLE. In particular, we focused on
the fact that the clearance of apoptotic cells by macrophages is
critical for the control of tissue homeostasis, and that an
impairment in the uptake of apoptotic cells can lead to the
generation of autoantibodies to nuclear antigens and the activation
of (auto)immune cells. [11–12] We found that leptin promoted
availability of apoptotic cell-derived antigen in lupus mice which,
in turn, favored expansion of antigen-reactive T cells.
Materials and Methods
Mice
(NZB6NZW) F1 (NZB/W), C57Bl6 (B6), DO.11.10 transgenic
mice (that carry a TCR specific for OVA323–339 peptide), and
leptin-receptor-deficient (db/db) (B6db/db) mice were purchased
from The Jackson Laboratory (Bar Harbor, ME) and housed at
the University of California Los Angeles (UCLA). The study was
carried out in strict accordance with the recommendations in the
Guide for the Care and Use of Laboratory Animals of the National
Institutes of Health with a protocol approved by the UCLA
Animal Research Committee. Female mice, aged 8–10 weeks,
were used in the experiments.
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Reagents
Recombinant mouse leptin was purchased from R&D Systems
(Minneapolis, MN). Anti-leptin Ab was from Cell Sciences
(Canton, MA). Before use, reagents were treated with Pierce
High Capacity Endotoxin Removal Resin (Thermo Scientific,
Rockford, IL).
Flow cytometry
Phenotypic analyses were performed with combinations of
fluorochrome-conjugated Ab (all from eBioscience, San Diego,
CA) using standard techniques and acquired with a FACSCalibur
flow cytometer (BD Biosciences, San Jose, CA). Data analysis was
done using FloJo software (Tree Star Inc., Ashland, OR).
Cell preparation
Jurkat T cells purchased from the American Type Culture
Collection (ATCC, Manassas, VA) were labeled with CFSE
(carboxyfluorescein succinimidyl ester; Sigma-Aldrich, St. Louis,
MO) and made apoptotic (as confirmed in flow cytometry by
annexin V and 7-aminoactinomycin (7-AAD) staining using BD
Biosciences kit) following exposure for 10 min at 254 nm UV and
subsequent incubation for 2 h in medium. Necrotic cell death was
induced by incubation at 55uC for 15 min. [13] Each of these
treatments consistently resulted in.85% cell death, as determined
by changes in forward and side scatter characteristics in flow
cytometry (not shown).
Phagocytosis in vivo
To recruit macrophages into the peritoneum, mice were
injected i.p. with 3 ml of 3% thioglycolate. Although thioglycolate
treatment associated with a ,10-fold increase in the number of
circulating macrophages, it did not influence their surface
expression of leptin receptor (assessed by flow cytometry as MFI,
not shown). Contralateral i.p. injection of recombinant mouse
leptin (6 consecutive doses of 2 mg/g at 12-h intervals) or vehicle
was given starting at the time of thioglycolate treatment. At day 3
post-injection, mice were infused i.p. with 16107 CFSE-labeled
apoptotic Jurkat cells. After 30 min, peritoneal cells were
recovered. To remove erythrocytes and non-phagocytosed bodies,
cells were incubated on polystyrene dishes for 1 h, and then
washed. For determination of macrophage uptake of apoptotic
Figure 1. Leptin modulates the uptake of apoptotic cells in vitro from lupus macrophage. Peritoneal macrophages (MW) from NZB/W
lupus mice (A–B) or leptin-receptor-deficient (non-autoimmune) db/db mice (C–D) were co-cultured ex vivo with 16107 CFSE-labeled apoptotic cells
(A, C) or necrotic cells (B, D) in the presence of scalar doses of leptin (x axis). After 2 h, cells were stained with PE-labeled anti-mouse CD11b Ab and
the labeled phagocytosed material within macrophages (PE-positive) was visualized as co-staining in flow cytometry. Additional details are reported
in the Methods. *p,0.01 vs no (0) leptin.
doi:10.1371/journal.pone.0112826.g001
Figure 2. Leptin promotes phagocytosis by lupus macrophages in vivo. NZB/W mice were injected i.p. with thioglycolate prior to injection of
either vehicle (A–C) or 2 mg/g leptin (D–F) at 12-h intervals. After 72 h, 16106 CFSE-positive apoptotic cells were injected i.p. After 30 min, uptake of
apoptotic cells by CD11b+ macrophages (PE) in peritoneal fluid of recipient animals was visualized ex vivo by confocal microscopy as colocalization of
PE-positive macrophages (red) and CFSE-positive (green) apoptotic bodies within the same cell (yellow). Representative of three experiments (n = 6
per group). Original magnification: 10x. (G) Cumulative flow cytometry of peritoneal macrophages costaining for apoptotic cells. *p,0.01 vs control.
doi:10.1371/journal.pone.0112826.g002
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cells (CFSE+) by flow cytometry, collected cells were stained with
PE-conjugated anti-mouse CD11b Ab. For confocal microscopy,
cells were resuspended in 1% cold BSA/PBS, centrifuged in a
Shandon Cytospin 3 centrifuge (Thermo Fisher Scientific,
Waltham, MA), and dried sediments were fixed with 220uC
acetone, blocked with 3% BSA/PBS, and stained with anti-mouse
CD11b Ab before visualization with a LSM 310 laser scanning
confocal microscope (Carl Zeiss Inc., Toronto, Canada).
Phagocytosis in vitro
Three days after thioglycolate injection, peritoneal macrophages
were collected from abdominal cavities and co-cultured in serum-
free HL-1 medium (Lonza, Anaheim, CA) with CFSE-labeled
apoptotic Jurkat T cells (16107 cells) in the presence of scalar
doses of leptin. After 2 h, cells were stained with anti-mouse
CD11b Ab (BioLegend, San Diego, CA). Macrophage uptake of
apoptotic cells was assessed by flow cytometry as co-staining for
CFSE and anti-CD11b Ab.
Measurement of cAMP
cAMP levels were detected using the Cyclic AMP EIA Kit
(Cayman Chemical Co., Ann Arbor, MI), according to the
manufacturer’s instructions.
Antigen presentation assay
After 1 h adherence of peritoneal macrophages at 37uC in HL-1
medium, non-adherent cells were removed by washing, and
macrophages cultured for 2 h at 37uC with 20 mg/ml ovalbumin
(OVA), labeled with TAMRA (5-carboxytetramethylrhodamine;
Genaxxon Bioscience, Ulm, Germany). Adherent cells were then
washed, sorted for TAMRA dye positivity, and induced to
apoptose by treatment with 1 mg/ml lipopolysaccharide (LPS)
(Sigma-Aldrich) for 4 h followed by addition of 5 mM ATP
(Sigma-Aldrich) for another 45 min. Harvested material was
washed before use as source of OVA-containing apoptotic bodies.
To study OVA-TCR transgenic T cell responses to OVA-
containing apoptotic bodies, OVA-TCR transgenic DO11.10
mice were immunized s.c. with 2 mg OVA (Sigma-Aldrich)
emulsified 1:1 in complete Freund adjuvant (CFA) (Sigma-
Aldrich). After 72 h, mice were sacrificed, splenocytes stained
with CFSE, and cocultured with TAMRA-labeled apoptotic
bodies containing OVA (see above) in the presence of scalar
doses of leptin or vehicle for 48 h before staining with clonotype-
specific KJ1.26 Ab (eBioscience) and flow cytometry for enumer-
ation of OVA-specific T cells.
Statistical analyses
Two-sided t test was used for two-group comparisons. Statistical
analyses were done using Prism 5 software (GraphPad, San
Diego). A p-value ,0.05 was considered significant.
Results and Discussion
Leptin promotes lupus macrophage phagocytosis
in vitro
In SLE, the impaired clearance of apoptotic cells causes an
accumulation of cellular material that contains self-antigen. [1–
2,14] To test a possible role of leptin in this process, we co-cultured
- in the presence of scalar doses of leptin - purified macrophages
derived from NZB/W lupus mice (obtained according to the
protocol shown in figure S1) together with CFSE-labeled apoptotic
cells. After 2 h in co-culture, a dose-dependent increase in the
uptake of apoptotic cells by lupus macrophages was observed in
the presence of increasing concentrations of leptin (figure 1A).
Leptin did not modulate the phagocytic capacity of macrophages
for non-apoptotic cells (figure 1B). Specificity of the results was
indicated by lack of effects of leptin on macrophages in leptin-
deficient (db/db) macrophages (figure 1C–D).
Leptin promotes lupus macrophage phagocytosis in vivo
Since the above findings suggested an ability of leptin to
promote phagocytosis in macrophages, we determined whether
similar effects could also be observed in vivo. To this aim, labeled
apoptotic cells were injected i.p. into two groups of NZB/W mice
that had been pre-treated with thioglycolate 3 days earlier. One
group of mice received leptin in addition to apoptotic cells, the
other (control) group of mice received vehicle together with
apoptotic cells. It was found that leptin-treated mice had a
significant increase in macrophage phagocytosis of apoptotic cells
when compared to control mice that had been treated with vehicle
(figure 2A–F). In particular, leptin-treated mice displayed a ,3-
fold increase in the frequency of phagocytosed apoptotic cells as
compared to controls (figure 2G). Those effects of leptin on
macrophages were lupus-specific as not observed in control
C57Bl.6 mice under the same experimental conditions (not shown)
and were not due to a modulation of macrophages recruitment
in vivo, because the total numbers of peritoneal macrophages
were comparable between animals treated with leptin or with
vehicle (figure 3).
Figure 3. Leptin does not influence peritoneal macrophage
recruitment. Total number of peritoneal macrophages recovered
three days after i.p. thioglycolate in NZB/W mice in that had been
injected i.p. with vehicle (control) or leptin. Further details can be found
in the Methods. p not significant.
doi:10.1371/journal.pone.0112826.g003
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Leptin modulates cAMP levels in macrophages
cAMP is produced during phagocytosis [15], where it acts as
second messenger in a signaling cascade that leads to downstream
activation of the suppression of phagocytosis and facilitation of the
production of proinflammatory mediators [16].
The analysis of the levels of cAMP in macrophages cultured in
the presence of scalar doses of leptin showed no significant changes
in intracellular cAMP expression (figure 4A). However, cAMP
levels were reduced in supernatants of cultured macrophages in
the presence of increasing concentrations of leptin (figure 4B),
suggesting a transient effect of leptin on macrophage production of
cAMP that is not maintained over time.
The uptake of apoptotic cells induced by leptin in
macrophages promotes proliferation of T cells reactive to
apoptotic-cell antigen
Macrophages that phagocytose apoptotic cells contain the self-
antigen that is present in apoptotic bodies. [17] Self-antigens are
known to represent driving factors in the generation and
maintenance of autoimmune responses. [18] Considering that
our results had indicated an ability of leptin to facilitate the uptake
of apoptotic cells by macrophages (figures 1 and 2), we assessed the
impact of availability of intracellular (apoptotic-derived) antigen to
macrophages on the proliferation of T cells reactive to that
antigen. Macrophages from DO11.10 mice (carrying the DO11.10
transgenic TCR reactive to OVA) were fed OVA, stained with
TAMRA, and made apoptotic (see Methods for more details).
Apoptotic bodies containing OVA (TAMRA+) were then incu-
bated with CFSE-labeled splenocytes from OVA-immunized
DO11.10 mice for 2 h in the presence of scalar doses of leptin.
Flow cytometry for CD11b+TAMRA+CFSE+ cells showed that
leptin had promoted phagocytosis of OVA-containing apoptotic
bodies in the splenic macrophages (figure 5A). Additionally, the
increased frequency of DO11.10 clonotype-specific KJ1.26+ T
cells reactive to OVA 48 h after treatment with leptin in the
cocultures of splenocytes with OVA-loaded macrophages indicat-
ed a promoting activity of leptin on the proliferation of the splenic
OVA-reactive T cells (figure 5B). This finding is consistent with
our recent observations that showed that leptin could promote
survival and proliferation of autoreactive CD4+ T cells [19–20].
Since leptin levels are abnormally elevated in NZB/W lupus
mice and in SLE patients, [9–10] these results suggest the
possibility that leptin could sustain autoimmune responses by
facilitating availability of apoptotic material that contains antigen
Figure 4. Effects of leptin on cAMP levels in macrophages. cAMP was measured as intracellular (A) and in supernatant (B) of NZB/W
macrophages cultured 1 h with scalar doses of leptin (see Methods for further details). Representative of three experiments in triplicate. *p,0.05 vs
control (0)
doi:10.1371/journal.pone.0112826.g004
Figure 5. Increased macrophage uptake of apoptotic cells induced by leptin promotes proliferation of self antigen-reactive T cells.
TAMRA-labeled apoptotic bodies containing OVA (see Methods) were co-cultured with CFSE-labeled macrophages for 2 h, followed by staining with
APC-labeled anti-CD11b Ab and flow cytometry. (A) Frequency of TAMRA+CFSE+ CD11b+ cells (macrophages positive for OVA-containing apoptotic
bodies) in OVA-TCR transgenic mice (DO11.10) after culture in the presence of scalar doses of leptin. (B) Flow cytometry staining with clonotype-
specific KJ1.26 Ab (OVA-specific TCR) 48 h after co-incubation of OVA-immunized DO11.10 (OVA-TCR transgenic) mouse splenocytes with
macrophages containing OVA-loaded apoptotic bodies (TAMRA+). *p,0.05, **p,0.01 vs control (n = 5).
doi:10.1371/journal.pone.0112826.g005
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that can be recognized by antigen-specific T cells. In this sense,
our findings extend mechanistically the prior work that showed an
enhanced phagocytosis in murine macrophages induced by leptin
[21], where (type 1) macrophages (M1) expressing the leptin
receptor responded to leptin, producing pro-inflammatory IL-6
and TNF-a [22].
In summary, this manuscript shows that leptin can promote, via
cAMP, the phagocytosis of apoptotic bodies and subsequent
proliferation of T cells reactive to apoptosis-derived antigen. These
results imply that limiting the above processes, e.g. via leptin
blockade, could have effects in the modulation of autoimmune
responses in SLE.
Supporting Information
Figure S1 Experimental protocol. Mice were injected i.p.
with 3 ml 3% thioglycolate for i.p. recruitment of macrophages.
Treated mice were then divided into two groups: one receiving six
injections of 2 mg/g of leptin per body weight at 12-h intervals, the
other group receiving vehicle at the same time points. After 72 h,
peritoneal macrophages were recovered for experimental use.
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